Massive oxidative haemolysis and renal failure caused by high dose vitamin C

Matthew J Rees, Madeleine C Strach, Kate Burbury and Kelly-Anne Phillips
Med J Aust 2018; 209 (6): . || doi: 10.5694/mja17.00998
Published online: 17 September 2018

Clinical record

  • 1 Peter MacCallum Cancer Institute, Melbourne, VIC
  • 2 University of Melbourne, Melbourne, VIC


Competing interests:

No relevant disclosures.

  • 1. Creagan ET, Oertel CG, O’Fallon JR, et al. Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial. N Engl J Med 1979; 301: 687-690.
  • 2. Xue CC, Zhang AL, Lin V, et al. Complementary and alternative medicine use in Australia: a national population-based survey. J Altern Complement Med 2007; 13: 643-650.
  • 3. G6PD Deficiency Favism Association. G6PD deficit — drugs that should be avoided: official list. Associazione Italiana Favismo; 1996–2018. (viewed Aug 2017).
  • 4. Huang YC, Chang TK, Fu YC, Jan SL. C for colored urine: acute hemolysis induced by high-dose ascorbic acid. Clin Toxicol (Phila) 2014; 52: 984.
  • 5. Rees DC, Kelsey H, Richards JD. Acute haemolysis induced by high dose ascorbic acid in glucose-6-phosphate dehydrogenase deficiency. BMJ 1993; 306: 841-842.
  • 6. Campbell GD, Steinberg MH, Bower JD. Letter: ascorbic acid-induced hemolysis in G-6-PD deficiency. Ann Intern Med 1975; 82: 810.
  • 7. Mehta JB, Singhal SB, Mehta BC. Ascorbic-acid-induced haemolysis in G-6-PD deficiency. Lancet 1990; 336: 944.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.